Literature DB >> 14982507

Eosinophils: 'new' roles for 'old' cells.

A Munitz1, F Levi-Schaffer.   

Abstract

Prominent blood and tissue eosinophilia is manifested in a number of inflammatory states, particularly in allergic diseases. Eosinophils are a source of numerous cytokines and growth factors, thus in principle they can display both pro-inflammatory and anti-inflammatory activities as well as immunoregulatory ones. In this review, we will discuss the cross-talk between eosinophils and other cell types that they come in contact with in the inflammatory milieu, such as mast cells, fibroblasts and endothelial cells. 'New' roles for eosinophils in cancer and novel activatory signals will also be described.

Entities:  

Mesh:

Year:  2004        PMID: 14982507     DOI: 10.1111/j.1398-9995.2003.00442.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  41 in total

1.  Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.

Authors:  Lisa G Johnson; Stephen M Schwartz; Mari Malkki; Qin Du; Effie W Petersdorf; Denise A Galloway; Margaret M Madeleine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-11       Impact factor: 4.254

Review 2.  Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins.

Authors:  Rossana C N Melo; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

Review 3.  AllergoOncology: the role of IgE-mediated allergy in cancer.

Authors:  E Jensen-Jarolim; G Achatz; M C Turner; S Karagiannis; F Legrand; M Capron; M L Penichet; J A Rodríguez; A G Siccardi; L Vangelista; A B Riemer; H Gould
Journal:  Allergy       Date:  2008-07-26       Impact factor: 13.146

4.  Ribonuclease-Activated Cancer Prodrug.

Authors:  Gregory A Ellis; Nicholas A McGrath; Michael J Palte; Ronald T Raines
Journal:  ACS Med Chem Lett       Date:  2012-02-28       Impact factor: 4.345

5.  Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study.

Authors:  Anna E Prizment; Kristin E Anderson; Kala Visvanathan; Aaron R Folsom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-08       Impact factor: 4.254

Review 6.  Immunological hallmarks of stromal cells in the tumour microenvironment.

Authors:  Shannon J Turley; Viviana Cremasco; Jillian L Astarita
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

7.  Stimulation of the in vitro migration of ovine eosinophils by factors derived from the sheep scab mite, Psoroptes ovis.

Authors:  L A Wildblood; D G Jones
Journal:  Vet Res Commun       Date:  2006-12-23       Impact factor: 2.459

8.  Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.

Authors:  Rafael Carretero; Ibrahim M Sektioglu; Natalio Garbi; Oscar C Salgado; Philipp Beckhove; Günter J Hämmerling
Journal:  Nat Immunol       Date:  2015-04-27       Impact factor: 25.606

9.  Eosinophil activation of fibroblasts from chronic allergen-induced disease utilizes stem cell factor for phenotypic changes.

Authors:  Vladislav Dolgachev; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

10.  CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.

Authors:  Jennifer Kearley; Douglas S Robinson; Clare M Lloyd
Journal:  J Allergy Clin Immunol       Date:  2008-07-30       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.